---
title: "A systematic comparison of ATN biomarkers for monitoring longitudinal cognitive changes in Alzheimer's disease"
collection: publications
permalink: /publication/2025AlzDem
excerpt: 'This systematic study compares longitudinal changes in A/T/N biomarkers (amyloid-PET, tau-PET, plasma p-tau217, and MRI) for tracking cognitive changes in Alzheimer&#39;s disease, finding plasma p-tau217 to be a robust, cost-effective alternative to tau-PET.'
date: 2025-10-24
venue: 'Alzheimer&#39;s & Dementia, vol 21, issue 10, pp e70783.'
paperurl: 'https://doi.org/10.1002/alz.70783'
citation: 'Biel, D., Steward, A., Dewenter, A., Dehsarvi, A., Zhu, Z., Roemer‐Cassiano, S. N., Frontzkowski, L., Hirsch, F., et al. (2025). A systematic comparison of ATN biomarkers for monitoring longitudinal cognitive changes in Alzheimer&#39;s disease. Alzheimer&#39;s & Dementia, 21(10), e70783. https://doi.org/10.1002/alz.70783'
---

This research systematically evaluated the predictive strength of longitudinal changes in **Amyloid (A)**, **Tau (T)**, and **Neurodegeneration (N)** biomarkers—specifically amyloid-PET, tau-PET, plasma phosphorylated tau at threonine 217 (**p-tau217**), and cortical thickness changes from MRI—for monitoring cognitive decline in Alzheimer's disease. The study found that plasma p-tau217 and tau-PET changes, along with cortical thickness changes, accurately tracked cognitive decline, while amyloid-PET changes did not. This highlights **plasma p-tau217** as a **robust and cost-effective surrogate biomarker** for monitoring treatment response and disease progression in AD trials.

[Download paper here](https://doi.org/10.1002/alz.70783)

Recommended citation: Biel, D., Steward, A., Dewenter, A., Dehsarvi, A., Zhu, Z., Roemer‐Cassiano, S. N., Frontzkowski, L., Hirsch, F., et al. (2025). A systematic comparison of ATN biomarkers for monitoring longitudinal cognitive changes in Alzheimer's disease. Alzheimer's & Dementia, 21(10), e70783. https://doi.org/10.1002/alz.70783
